Omega Healthcare Investors/$OHI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Omega Healthcare Investors

Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).

Ticker

$OHI

Primary listing

NYSE

Employees

60

OHI Metrics

BasicAdvanced
$12B
25.82
$1.61
0.67
$2.68
6.44%

What the Analysts think about OHI

Analyst ratings (Buy, Hold, Sell) for Omega Healthcare Investors stock.

Bulls say / Bears say

The company raised its 2025 AFFO guidance for the second time, now projecting $3.04–$3.07 per diluted share. This reflects robust year-to-date investments of $605 million through June 2025 and strict expense control (8-K Q2.
In Q1 2025, Omega invested $423 million in new real estate and loan assets, including £259.8 million ($344.2 million) in UK facility acquisitions with annual rent of £25.9 million and rent escalators rising to 2.5%, strengthening portfolio income stability (8-K Q1.
Omega has maintained a quarterly cash dividend of $0.67 per share for 23 years, delivering an approximate 7% yield and demonstrating its dedication to shareholder returns (Investing.com).
Omega faces near-term refinancing risk, with its $1.45 billion unsecured revolving credit facility set to mature in October 2025 and a $428.5 million term loan due in August 2026. The company must extend these facilities in time to prevent liquidity pressure (8-K Q2.
The company has $247 million in mortgage and other real estate-backed loans maturing in 2025. Its guidance anticipates only partial repayments or conversions, which carries execution risk if market or operator conditions weaken (8-K Q1.
Omega recorded a $14.2 million net impairment charge in Q2 2025 to write down three facilities to fair value, highlighting potential headwinds in underlying asset values (8-K Q2.
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2025.

OHI Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

OHI Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $OHI

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs